Michel Debaert

621 total citations
51 papers, 382 citations indexed

About

Michel Debaert is a scholar working on Organic Chemistry, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Michel Debaert has authored 51 papers receiving a total of 382 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Organic Chemistry, 14 papers in Molecular Biology and 10 papers in Cellular and Molecular Neuroscience. Recurrent topics in Michel Debaert's work include Neuroscience and Neuropharmacology Research (8 papers), Analytical Chemistry and Chromatography (7 papers) and Synthesis of heterocyclic compounds (6 papers). Michel Debaert is often cited by papers focused on Neuroscience and Neuropharmacology Research (8 papers), Analytical Chemistry and Chromatography (7 papers) and Synthesis of heterocyclic compounds (6 papers). Michel Debaert collaborates with scholars based in France, Belgium and Australia. Michel Debaert's co-authors include Claude Vaccher, Pascal Berthelot, Nathalie Flouquet, Michel Luyckx, C. Brunet, David I.B. Kerr, Jennifer Ong, G. Evrard, F. Durant and J C Cazin and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Chromatography A and European Journal of Pharmacology.

In The Last Decade

Michel Debaert

44 papers receiving 368 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michel Debaert France 12 176 160 119 92 39 51 382
Nathalie Flouquet France 11 170 1.0× 232 1.4× 75 0.6× 86 0.9× 26 0.7× 31 394
Giancarlo Bettoni Italy 15 248 1.4× 220 1.4× 44 0.4× 161 1.8× 50 1.3× 41 510
Karen L Locker United Kingdom 7 124 0.7× 59 0.4× 77 0.6× 91 1.0× 22 0.6× 8 296
M. BOES United States 7 228 1.3× 401 2.5× 50 0.4× 86 0.9× 10 0.3× 10 540
A. M. Triggle United States 6 331 1.9× 237 1.5× 150 1.3× 36 0.4× 6 0.2× 11 566
Maristella Colombo Italy 10 134 0.8× 165 1.0× 61 0.5× 58 0.6× 16 0.4× 15 360
Paul A. Whetstone United States 12 229 1.3× 97 0.6× 36 0.3× 117 1.3× 19 0.5× 13 539
G. S. Sach Italy 8 113 0.6× 185 1.2× 83 0.7× 47 0.5× 5 0.1× 14 337
Denise Rathbone United States 7 139 0.8× 125 0.8× 82 0.7× 40 0.4× 7 0.2× 10 289
L.‐E. ARVIDSSON Sweden 11 285 1.6× 180 1.1× 232 1.9× 50 0.5× 4 0.1× 14 470

Countries citing papers authored by Michel Debaert

Since Specialization
Citations

This map shows the geographic impact of Michel Debaert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Debaert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Debaert more than expected).

Fields of papers citing papers by Michel Debaert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michel Debaert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Debaert. The network helps show where Michel Debaert may publish in the future.

Co-authorship network of co-authors of Michel Debaert

This figure shows the co-authorship network connecting the top 25 collaborators of Michel Debaert. A scholar is included among the top collaborators of Michel Debaert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel Debaert. Michel Debaert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kerr, David I.B., Jennifer Ong, Claude Vaccher, et al.. (1996). GABAB receptor antagonism by resolved (R)-saclofen in the guinea-pig ileum. European Journal of Pharmacology. 308(3). R1–R2. 5 indexed citations
2.
Berthelot, Pascal, Claude Vaccher, Nathalie Flouquet, et al.. (1996). 3-Benzo[b]furyl- and 3-benzo[b]thienylaminobutyric acids as GABAB ligands. Synthesis and structure-activity relationship studies. European Journal of Medicinal Chemistry. 31(6). 449–460. 13 indexed citations
3.
Vaccher, Claude, Pascal Berthelot, & Michel Debaert. (1995). GABA-B agonists: enantiomeric resolution of 4-amino-3-(5-chlorothien-2-yl)butyric acid and analogues on chiral crown ether stationary phase. Journal of Chromatography A. 715(2). 361–365. 6 indexed citations
4.
Pirard, Bernard, Pierre‐Alain Carrupt, Bernard Testa, et al.. (1995). Structure-affinity relationships of baclofen and 3-heteroaromatic analogues. Bioorganic & Medicinal Chemistry. 3(11). 1537–1545. 9 indexed citations
5.
Pirard, Bernard, G. Evrard, Bernadette Norberg, et al.. (1993). Crystal structures of baclofen analogs: 3-thienyl- and 3-furylaminobutyric acids. Journal of Chemical Crystallography. 23(11). 843–848. 5 indexed citations
6.
Vaccher, Claude, Pascal Berthelot, & Michel Debaert. (1993). Direct chromatographic separation of the enantiomers of phaclofen, saclofen and hydroxysaclofen. Journal of Chromatography A. 657(1). 213–218. 10 indexed citations
7.
Berthelot, Pascal, et al.. (1993). Thienyl-GABA derivatives as specific baclofen agonists in the rat and cat spinal cord in vivo. Neuroscience Letters. 159(1-2). 64–66. 6 indexed citations
8.
Vaccher, Claude, Pascal Berthelot, & Michel Debaert. (1993). The investigation of the mannich reaction of 4,5‐dimethyl‐1,2‐dithiole‐3‐thione. Journal of Heterocyclic Chemistry. 30(2). 545–547.
9.
Pirard, Bernard, G. Evrard, Bernadette Norberg, et al.. (1993). Crystal structure of 4‐amino‐3‐(2‐benzothiophen) butyric acid, a baclofen analogue. Bulletin des Sociétés Chimiques Belges. 102(10). 639–643. 4 indexed citations
10.
Ong, Jennifer, et al.. (1992). Differing actions of β-(2-thienyl)-γ-aminobutyric acid in central and peripheral preparations. European Journal of Pharmacology. 221(1). 145–149. 12 indexed citations
11.
Ong, Jennifer, et al.. (1992). Actions of thienyl analogs of baclofen in the guinea-pig isolated ileum. European Journal of Pharmacology. 218(2-3). 343–345. 10 indexed citations
12.
Berthelot, Pascal, Claude Vaccher, Nathalie Flouquet, et al.. (1991). 3-Thienyl- and 3-furylaminobutyric acids. Synthesis and binding GABAB receptor studies. Journal of Medicinal Chemistry. 34(8). 2557–2560. 64 indexed citations
13.
Berthelot, Pascal, Claude Vaccher, Nathalie Flouquet, et al.. (1991). Synthesis, pharmacology and X-ray studies of baclofen analogues. European Journal of Medicinal Chemistry. 26(4). 395–402. 16 indexed citations
14.
Vaccher, Claude, Pascal Berthelot, Nathalie Flouquet, & Michel Debaert. (1991). Preparative liquid chromatographic separation of isomers of 4-amino-3-(4-chlorophenyl)butyric acid. Journal of Chromatography A. 542. 502–507. 7 indexed citations
15.
Debaert, Michel, et al.. (1991). ChemInform Abstract: Synthesis of Some 2‐Benzoxazolinone Derivatives and Their Analgesic Properties.. ChemInform. 22(27). 1 indexed citations
16.
Beattie, David T., D.R. Curtis, Michel Debaert, Claude Vaccher, & Pascal Berthelot. (1989). Baclofen antagonism by 4-amino-3-(5-methoxybenzo[b]furan-2-yl) butanoic acid in the cat spinal cord. Neuroscience Letters. 100(1-3). 292–294. 16 indexed citations
17.
Kerr, David I.B., et al.. (1989). Benzofuran analogues of baclofen: a new class of central and peripheral GABAB-receptor antagonists. European Journal of Pharmacology. 164(2). 361–364. 21 indexed citations
18.
Vaccher, Claude, et al.. (1989). Electro-organic synthesis and X-ray crystal structure of the novel complex 2,7-dimethyl-6,8-bis(methylthio)pyrrolo[1,2-a]pyrazinium tri-iodomercurate(II). Journal of the Chemical Society Perkin Transactions 2. 391–391. 3 indexed citations
19.
Vaccher, Claude, Pascal Berthelot, Jean‐Louis Burgot, et al.. (1986). Recherche de propriétés antibilharziennes de dithiole-thiones, d'intermédiaires et de dérivés. 21(2). 123–130. 6 indexed citations
20.
Boivin, J.C., et al.. (1983). N-[(Ethyl-1 pyrrolidinyl-2)méthyl] hydroxy-2 sulfamoyl-5 benzamide (un métabolite du sulpiride), C14H21N3O4S. Acta Crystallographica Section C Crystal Structure Communications. 39(9). 1285–1287.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nathalie Flouquet Breakdown of academic impact, for papers by Giancarlo Bettoni Breakdown of academic impact, for papers by Karen L Locker Breakdown of academic impact, for papers by M. BOES Breakdown of academic impact, for papers by A. M. Triggle Breakdown of academic impact, for papers by Maristella Colombo Breakdown of academic impact, for papers by Paul A. Whetstone Breakdown of academic impact, for papers by G. S. Sach Breakdown of academic impact, for papers by Denise Rathbone Breakdown of academic impact, for papers by L.‐E. ARVIDSSON
Rankless by CCL
2026